176 related articles for article (PubMed ID: 21283706)
1. A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).
Bippes CC; Feldmann A; Stamova S; Cartellieri M; Schwarzer A; Wehner R; Schmitz M; Rieber EP; Zhao S; Schäkel K; Temme A; Scofield RH; Kurien BT; Bartsch H; Bachmann M
PLoS One; 2011 Jan; 6(1):e16315. PubMed ID: 21283706
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
3. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
[TBL] [Abstract][Full Text] [Related]
4. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
5. FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.
Döbel T; Kunze A; Babatz J; Tränkner K; Ludwig A; Schmitz M; Enk A; Schäkel K
Blood; 2013 May; 121(18):3609-18. PubMed ID: 23460612
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.
Wehner R; Wehrum D; Bornhäuser M; Zhao S; Schäkel K; Bachmann MP; Platzbecker U; Ehninger G; Rieber EP; Schmitz M
Haematologica; 2009 Aug; 94(8):1151-6. PubMed ID: 19546436
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
8. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
9. Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.
Wehner R; Bitterlich A; Meyer N; Kloß A; Schäkel K; Bachmann M; Schmitz M
Int J Cancer; 2013 Mar; 132(6):1351-9. PubMed ID: 22907335
[TBL] [Abstract][Full Text] [Related]
10. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
Döbel T; Schäkel K
J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
[TBL] [Abstract][Full Text] [Related]
11. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
Toma M; Wehner R; Kloß A; Hübner L; Fodelianaki G; Erdmann K; Füssel S; Zastrow S; Meinhardt M; Seliger B; Brech D; Noessner E; Tonn T; Schäkel K; Bornhäuser M; Bachmann MP; Wirth MP; Baretton G; Schmitz M
Oncoimmunology; 2015 Jun; 4(6):e1008342. PubMed ID: 26155414
[TBL] [Abstract][Full Text] [Related]
13. slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils [corrected].
Micheletti A; Finotti G; Calzetti F; Lonardi S; Zoratti E; Bugatti M; Stefini S; Vermi W; Cassatella MA
Oncotarget; 2016 Jan; 7(1):161-75. PubMed ID: 26695549
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
Mager K; Wehner R; Bahr F; Oelschlägel U; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Radke J; Röllig C; Schetelig J; Thiede C; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Transplantation; 2012 Jun; 93(12):1270-5. PubMed ID: 22643330
[TBL] [Abstract][Full Text] [Related]
15. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
Günther C; Starke J; Zimmermann N; Schäkel K
Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
[TBL] [Abstract][Full Text] [Related]
16. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
Tufa DM; Chatterjee D; Low HZ; Schmidt RE; Jacobs R
Eur J Immunol; 2014 Dec; 44(12):3717-28. PubMed ID: 25229755
[TBL] [Abstract][Full Text] [Related]
17. Increased Numbers of 6-sulfo LacNAc (slan) Dendritic Cells in Hand Transplant Recipients.
Baran W; Koziol M; Woźniak Z; Banasik M; Boratyńska M; Kunze A; Schakel K
Ann Transplant; 2015 Oct; 20():649-54. PubMed ID: 26510404
[TBL] [Abstract][Full Text] [Related]
18. Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Thomas K; Dietze K; Wehner R; Metz I; Tumani H; Schultheiß T; Günther C; Schäkel K; Reichmann H; Brück W; Schmitz M; Ziemssen T
Neurol Neuroimmunol Neuroinflamm; 2014 Oct; 1(3):e33. PubMed ID: 25340085
[TBL] [Abstract][Full Text] [Related]
19. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
20. TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells.
Jähnisch H; Wehner R; Tunger A; Kunze A; Oehrl S; Schäkel K; Rohayem J; Bornhäuser M; Tonn T; Bachmann M; Schmitz M
Cancer Lett; 2013 Jul; 335(1):119-27. PubMed ID: 23402811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
